These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29950152)

  • 1. IL-33 Promotes the Development of Colorectal Cancer Through Inducing Tumor-Infiltrating ST2L
    Zhou Y; Ji Y; Wang H; Zhang H; Zhou H
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818780091. PubMed ID: 29950152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of a CD4
    Jafarinia M; Mehdipour F; Hosseini SV; Ghahramani L; Hosseinzadeh M; Ghaderi A
    Tumour Biol; 2016 Nov; 37(11):14659-14666. PubMed ID: 27619682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ST2 Signaling in the Tumor Microenvironment.
    Chang CP; Hu MH; Hsiao YP; Wang YC
    Adv Exp Med Biol; 2020; 1240():83-93. PubMed ID: 32060890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer.
    Pastille E; Wasmer MH; Adamczyk A; Vu VP; Mager LF; Phuong NNT; Palmieri V; Simillion C; Hansen W; Kasper S; Schuler M; Muggli B; McCoy KD; Buer J; Zlobec I; Westendorf AM; Krebs P
    Mucosal Immunol; 2019 Jul; 12(4):990-1003. PubMed ID: 31165767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma.
    Liyanage UK; Goedegebuure PS; Moore TT; Viehl CT; Moo-Young TA; Larson JW; Frey DM; Ehlers JP; Eberlein TJ; Linehan DC
    J Immunother; 2006; 29(4):416-24. PubMed ID: 16799337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the IL-33/ST2L axis in colorectal cancer progression.
    Akimoto M; Takenaga K
    Cell Immunol; 2019 Sep; 343():103740. PubMed ID: 29329638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-36α inhibits colorectal cancer metastasis by enhancing the infiltration and activity of CD8
    Wei X; Yao Y; Wang X; Sun J; Zhao W; Qiu L; Zhai W; Qi Y; Gao Y; Wu Y
    Int Immunopharmacol; 2021 Nov; 100():108152. PubMed ID: 34555640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment.
    Akimoto M; Maruyama R; Takamaru H; Ochiya T; Takenaga K
    Nat Commun; 2016 Nov; 7():13589. PubMed ID: 27882929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-17 inhibits CXCL9/10-mediated recruitment of CD8
    Chen J; Ye X; Pitmon E; Lu M; Wan J; Jellison ER; Adler AJ; Vella AT; Wang K
    J Immunother Cancer; 2019 Nov; 7(1):324. PubMed ID: 31775909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th22 cell accumulation is associated with colorectal cancer development.
    Huang YH; Cao YF; Jiang ZY; Zhang S; Gao F
    World J Gastroenterol; 2015 Apr; 21(14):4216-24. PubMed ID: 25892871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
    Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
    Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of FoxP3+ T regulatory cells in the tumor microenvironment of human colorectal adenomas.
    Hua W; Yuan A; Zheng W; Li C; Cui J; Pang Z; Zhang L; Li Z; Goll R; Cui G
    Pathol Res Pract; 2016 Feb; 212(2):106-12. PubMed ID: 26724144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treg-cell depletion promotes chemokine production and accumulation of CXCR3(+) conventional T cells in intestinal tumors.
    Akeus P; Langenes V; Kristensen J; von Mentzer A; Sparwasser T; Raghavan S; Quiding-Järbrink M
    Eur J Immunol; 2015 Jun; 45(6):1654-66. PubMed ID: 25754875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
    Saito T; Nishikawa H; Wada H; Nagano Y; Sugiyama D; Atarashi K; Maeda Y; Hamaguchi M; Ohkura N; Sato E; Nagase H; Nishimura J; Yamamoto H; Takiguchi S; Tanoue T; Suda W; Morita H; Hattori M; Honda K; Mori M; Doki Y; Sakaguchi S
    Nat Med; 2016 Jun; 22(6):679-84. PubMed ID: 27111280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of anti-cancer and immunomodulatory effects of carnosol in a Balb/c WEHI-164 fibrosarcoma model.
    Rahnama M; Mahmoudi M; Zamani Taghizadeh Rabe S; Balali-Mood M; Karimi G; Tabasi N; Riahi-Zanjani B
    J Immunotoxicol; 2015; 12(3):231-8. PubMed ID: 25027673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foxp3 expression in CD4
    Zhu XW; Zhu HZ; Zhu YQ; Feng MH; Qi J; Chen ZF
    J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):677-682. PubMed ID: 27752897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation of interaction between IL-33 and ST2+ regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration.
    Noel G; Arshad MI; Filliol A; Genet V; Rauch M; Lucas-Clerc C; Lehuen A; Girard JP; Piquet-Pellorce C; Samson M
    Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G313-23. PubMed ID: 27340126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
    Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
    J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer.
    O'Donnell C; Mahmoud A; Keane J; Murphy C; White D; Carey S; O'Riordain M; Bennett MW; Brint E; Houston A
    Br J Cancer; 2016 Jan; 114(1):37-43. PubMed ID: 26679377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.